SYNEXUS LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -21.4%

  £15,126,929 → £11,888,759

  lowest in 5 filed years

• Cash

  +1,146%

  £58,610 → £730,306

  highest in 5 filed years

• Net assets

  +14.7%

  £4,585,055 → £5,257,810

  highest in 5 filed years

• Employees

  -6.9%

  145 → 135

  lowest in 5 filed years

• Operating profit

  -22.7%

  £945,703 → £730,561

  lowest in 5 filed years

• Profit before tax

  -12.8%

  £946,735 → £825,616

  lowest in 5 filed years

• Wages

  -6.9%

  £6,593,323 → £6,141,284

  lowest in 5 filed years

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. SYNEXUS LIMITED 2001-03-01 → present
2. STYLISHPURSUITS LIMITED 1999-03-02 → 2001-03-01

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Forvis Mazars LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Having regard to the current financial position of both the Company and Group the current Company order book together with financial forecasts and strategic plans for future periods; the directors believe that the Company is well placed to manage its business risks successfully. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being at least the forthcoming 12 months. Accordingly, they continue to adopt the going concern basis in preparing the financial statements and believe that the company is well placed to manage its business risks successfully.”

Significant events

• “In 2024 Synexus continued to evolve under Thermo Fisher Scientific Inc. and under the Accelerated Enrolment Services (AES) brand, which brings together the site network capabilities of Synexus, the patient enrolment services of Acurian Inc and the Vaccines and Oncology specialism of Optimal Research. Both Acurian and Optimal Research are group companies under Thermo Fisher Scientific Inc.”
• “Synexus continued to build its capacity to service growing demand from customers by partnering with new sites and business in Europe, Latin America, and China, further adding to the extensive global outreach of the group.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.